Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in South Dakota. Pick another state for the same tag.
Against expectation — 2023
South Dakota cites F756 less often than its own record predicts
Versus expected share0.77×
0.77 times the national share — cited less often here than elsewhere.
Share of South Dakota citations0.72%
Of every deficiency written in South Dakota in 2023, this is the portion that was F756.
South Dakota0.72%
National0.94%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What South Dakota surveyors wrote
F756 findings written in South Dakota, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 20, 2026
Based on record review, interview, and policy review, the provider failed to ensure pharmacist recommendations from the resident's monthly medication reviews were addressed by the physician for one of one sampled resident (5) and physician orders were entered into the resident's electronic medical record (EMR) for one of one sampled residents (6) regarding psychotropic medications (drugs that affect brain activities associated with mental processes and behavior). Findings include:1. Review of resident 5's electronic medical record (EMR) revealed he admitted to the facility on [DATE]. His 7/20/26 Brief Interview for Mental Status (BIMS) assessment score was 00, which indicated that his cognition was severely impaired. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction